bluebird bio (BLUE) Announces $400M Common Stock Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
bluebird bio (BLUE) Prices 2.9M Common Share Offering at $170/Share
June 24, 2015 7:23 AM EDTOvernight, bluebird bio (NASDAQ: BLUE) announced the pricing of an underwritten public offering of 2,941,176 shares of its common stock at a public offering price of $170.00 per share, before underwriting discounts. In addition, bluebird bio has granted the underwriters a 30-day option to purchase... More
